Walleye Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-66,350
| Closed | -$12.2K | – | 2027 |
|
|
2021
Q2 | $12.2K | Buy |
66,350
+25,983
| +64% | +$4.77K | 0.42% | 11 |
|
|
2021
Q1 | $6.17K | Buy |
40,367
+7,614
| +23% | +$1.16K | 0.36% | 31 |
|
|
2020
Q4 | $5.12K | Buy |
32,753
+30,332
| +1,253% | +$4.74K | 0.34% | 30 |
|
|
2020
Q3 | $277K | Buy |
+2,421
| New | +$277K | 0.03% | 509 |
|
|
2020
Q2 | – | Sell |
-15,446
| Closed | -$1.39M | – | 858 |
|
|
2020
Q1 | $1.39M | Sell |
15,446
-2,960
| -16% | -$266K | 0.31% | 69 |
|
|
2019
Q4 | $1.99M | Buy |
18,406
+17,347
| +1,638% | +$1.88M | 0.13% | 37 |
|
|
2019
Q3 | $103K | Buy |
1,059
+859
| +430% | +$83.5K | 0.01% | 283 |
|
|
2019
Q2 | $26K | Hold |
200
| – | – | ﹤0.01% | 374 |
|
|
2019
Q1 | $27K | Buy |
+200
| New | +$27K | ﹤0.01% | 276 |
|
|
2018
Q3 | $295K | Buy |
+2,125
| New | +$295K | 0.14% | 161 |
|